Navigation Links
Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
Date:9/13/2007

ecutive officer. Dr. Ueno founded Sucampo Pharmaceuticals in 1996 with Sachiko Kuno, Ph.D., founding CEO and advisor, international business development. Sucampo Pharmaceuticals' first product, AMITIZA(R), received marketing approval from the U.S. Food and Drug Administration in January 2006 for the treatment of Chronic Idiopathic Constipation in adults. AMITIZA is co-promoted in the United States and Canada through an alliance between Sucampo Pharmaceuticals and Takeda Pharmaceutical Company Limited (Osaka, Japan). Sucampo Pharmaceuticals' sales force targets the institutional marketplace, including academic medical centers and long- term care facilities, while Takeda focuses on office-based specialty and primary care physicians. To learn more about Sucampo Pharmaceuticals and its products, visit http://www.sucampo.com.

Takeda Pharmaceuticals North America, Inc.

Based in Deerfield, Ill., Takeda Pharmaceuticals North America, Inc. is a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. In the United States, Takeda currently markets products for diabetes, insomnia, wakefulness and gastroenterology. The company has a robust pipeline with compounds in development for diabetes, cardiovascular disease and other conditions. Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products. To learn more about the company and its products, visit http://www.tpna.com.

Forward-Looking Statements

Any statements in this press release about future expectations, plans and prospects for Sucampo Pharmaceuticals, Inc. are forward-looking statements made under the provisions of The Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the words "project," "believe," "anticipate," "plan,"
'/>"/>

SOURCE Sucampo Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
2. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
3. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data on Molecular Imaging Pharmaceutical for Prostate Cancer
4. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data at Society Of Nuclear Medicine 2007 Annual Meeting
5. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
6. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
7. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
8. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
9. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
10. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
11. Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... N.C. , April 17, 2015  Healthcare ... creation of many new forms of provider networks, ... Care Organizations (ACOs). The rapid evolution of these ... adapt their access, pricing and service delivery systems ... To help the pharma sector adapt ...
(Date:4/17/2015)... 17, 2015 Research and Markets ... the "Medical Device Outsourcing - Global Strategic ... This report analyzes the worldwide markets for ... following Device Categories: Class I, Class II, and ... the report Include - Radiology, Orthopedic, Neurology, Cardiology, ...
(Date:4/17/2015)... April 17, 2015  Trovagene, Inc., (NASDAQ:  TROV) ... that clinical data presented at the 2015 European ... Precision Cancer Monitoring ℠ (PCM) platform outperformed ... EGFR T790M mutations in metastatic lung ... EGFR T790M Mutation in Urinary Circulating Tumor DNA ...
Breaking Medicine Technology:Pharmaceutical Industry Struggling to Better Serve Provider Networks Such as Accountable Care Organizations (ACOs) 2Medical Device Outsourcing (Radiology, Orthopedic, Neurology, Cardiology, and Others) Market 2015 - Global Strategic Business Report 2Medical Device Outsourcing (Radiology, Orthopedic, Neurology, Cardiology, and Others) Market 2015 - Global Strategic Business Report 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 4
(Date:4/17/2015)... WA (PRWEB) April 17, 2015 ERGO-Pedic ... cushions is introducing two new products to help a ... low back pain relief are the second most common ... our first product, designed specifically to help relieve sitting ... Comfort Cushion, and thousands of happy customers later, we ...
(Date:4/17/2015)... April 17, 2015 Alcohol and Violence ... (NCADD) notes that drinking and driving has been the ... the same time, the link between alcohol and crime ... abuse and violence and sexual assault, and their relationship ... the NCADD, 5.3 million adults in America were drinking ...
(Date:4/17/2015)... “We have seen healing, a lot of healing, ... said Chaplain Shawn Kafader of Friendship Village. “People have ... anything to contribute have created beautiful pieces of art.” For ... therapy program that was launched to benefit residents of the ... of the Art Institute in Chicago, worked as an intern ...
(Date:4/17/2015)... In Defense of Christians (IDC) Executive Director ... April 15th, the European Parliament joined its voice with ... Armenian Genocide, “paying tribute, on the eve of the ... Armenian victims who perished in the Ottoman Empire.” ... this timely and needed recognition of a tragic episode ...
(Date:4/17/2015)... 17, 2015 Representatives Jim Himes (D-CT) ... Treatment Act HR 1849 in congress on April 16, ... treatment for patients with the genetic disease. , ... would be the first to create a federally led ... of hereditary hemorrhagic telangiectasia. This would effectively prevent premature ...
Breaking Medicine News(10 mins):Health News:Seat Cushion Company Credits Customer Driven Design For Two New Products 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 3Health News:Healing At Friendship Village Due To Art Therapy 2Health News:In Defense of Christians Condemns Armenian Genocide 2Health News:In Defense of Christians Condemns Armenian Genocide 3Health News:House Representatives Introduce Bill to Fight Genetic Disease 2
... Expert Addresses Impact of Technology on Health; Fitness Expert ... Denise Austin Offers Nightly Wellness Tips, MORRIS PLAINS, N.J., ... reach for your cell phone or your gym bag? A new ... Americans are busier than ever before, often at the expense of,their ...
... MIAMI, April 24 Physicians Healthcare,Management Group, Inc. ... organizations (HMOs) in partnership with physicians,today announced that ... signed an agreement with Advantica EyeCare to provide,comprehensive ... be launched in,the latter half of 2008., ...
... announced that it will release first quarter 2008,financial results on Thursday, May ... The Company will host a conference call to discuss the first quarter,2008 ... First Quarter 2008 Earnings Conference Call, ... Thursday, May 1, 2008 at 5:00 p.m. Eastern Time, Dial-in: ...
... Best Gifts to Receive This Season are Those That Give Back and ... the Fight Against AIDS ... off,the Mother,s Day festivities a few weeks early at the INSPI(RED) Mothers,Brunch ... by Helena Christensen, Liya Kebede, Mya, and other (RED) supporters,to celebrate motherhood ...
... Lauren Center for Cancer Care and ... Prevention Are the First to Be Certified, NEW ... today announced that representatives from the Leukemia,& Lymphoma Society and ... the first to be certified and representatives from,the Cleveland Clinic ...
... Was Served, -, LOS ANGELES, April 23 ... against Yolanda McGriff, a Los Angeles-,based healthcare worker who ... a low-income, disabled veteran. McGriff was arrested for,trespass-related violations ... employer, a man who lived in what used to ...
Cached Medicine News:Health News:Wired, Working Americans Let Nighttime Health Routines Slide 2Health News:Wired, Working Americans Let Nighttime Health Routines Slide 3Health News:Wired, Working Americans Let Nighttime Health Routines Slide 4Health News:Phyhealth Signs Agreement with Advantica EyeCare to Provide Vision Services for Pilot HMO 2Health News:Get INSPI(RED) This Mother's Day 2Health News:Get INSPI(RED) This Mother's Day 3Health News:Get INSPI(RED) This Mother's Day 4Health News:Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications 2Health News:Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications 3Health News:Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications 4Health News:Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications 5Health News:Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications 6Health News:Case Dropped Against Healthcare Worker Who Was Arrested While Providing Care to an Elderly, Disabled Man in Los Angeles Home 2
... C.B.S.SCIENTIFIC offers four different Series ... EPS-3000-II, the EPS-4000-II, and the EPS-6000-II. ... voltage, constant current, and constant power ... a powerful 300 milliamps maximum current/300 ...
... The PowerPac Basic power supply, ... output of 10-300 V, 4-400 ... unit contains a built-in switch ... with the appropriate power cord. ...
... Granular, free-flowing powder EEO (-m r ): 0.05 ... Remelt Point (1.5%): 88.0 1.5C Gel Strength ... 2 Gel Strength (1.5%): greater than or ... than or equal to 7% Turbidity (1.5%): less ...
... (Cl) ≤ 5000 mg/kg sulfate (SO 4 ) ≤ ... ≤ 5 mg/kg Co ≤ 5 mg/kg Cr ≤ ... mg/kg K ≤ 50 mg/kg Mg ≤ 5 mg/kg ... ≤ 5 mg/kg Pb ≤ 5 mg/kg Zn ≤ ...
Medicine Products: